As part of our effort to elevate the importance of genetic testing, and the role it can play in shortening the diagnostic journey for children living with a neurologic condition, we are working to expand the usage of genetic testing in the diagnostic process.
Thanks to the generous support of Illumina, we will be able to provide whole genome sequencing (WGS) at no cost to a limited number of patients, aside from possible routine venipuncture costs.
In 2021, up to 5 medical sites and 20 children who have not previously received a molecular diagnosis in the US will be selected to receive WGS. It’s important to note that applications will only be accepted from medical professionals.
For more information about eligibility and to apply, please visit our webpage.